Home・Listă Acțiuni・Ocugen Inc

Ocugen Inc

Închisă

1.44 8.27

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

1.32

Maxim

1.37

Indicatori cheie
By Trading Economics
Venit	-5.7M -25M
Vânzări	-45K 1.5M
EPS	-0.07
Marjă de profit	-1,671.841
Angajați	116
EBITDA	-2.5M -20M

Recomandări
By TipRanks
Recomandări	Puternic Cumpărare
Prognoză pe 12 luni	+642.75% upside

Dividende
By Acuity
Următoarele câștiguri	4 nov. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	41M 458M
Deschiderea anterioară	-6.83
Închiderea anterioară	1.44

Ocugen Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

18 aug. 2026, 23:56 UTC

Correlated Moves

Hecla Mining Co shares are lower in after-market trading, pressured by declining silver prices and rising sovereign bond yields amid inflation concerns.

18 aug. 2026, 23:56 UTC

Huntington Ingalls Industries shares are higher in after-market trading, reflecting strength above its 20-day moving average and near the upper end of its one-month range.

18 aug. 2026, 23:56 UTC

News

Exelixis shares are lower in after-market hours following BMO's Market Perform rating. Broader market pressures from rising bond yields also weigh on the stock.

18 aug. 2026, 23:56 UTC

American Water Works shares are higher in after-market trading, despite rising sovereign bond yields impacting investor sentiment across equities.

18 aug. 2026, 23:56 UTC

Coursera Inc shares are higher in after-market trading, despite no specific news driving the movement. Broader market conditions reflect rising sovereign bond yields.

18 aug. 2026, 23:56 UTC

Correlated Moves

Social Media

The iShares Core U.S. Aggregate Bond ETF rose slightly in after-market trading, reflecting recent fluctuations in the 10-year yield and broader market sentiment.

18 aug. 2026, 23:56 UTC

Steel Dynamics Inc shares are trading lower in after-market hours, remaining below the 20-day moving average amid ongoing market weakness. No specific news was identified.

18 aug. 2026, 23:56 UTC

Chipotle Mexican Grill Inc shares are higher in after-market trading, reflecting a modest increase since Tuesday's close amid rising sovereign bond yields.

18 aug. 2026, 23:56 UTC

Array Technologies Inc shares are higher in after-market trading, reflecting a modest gain since Tuesday's close. The stock remains below its 20-day moving average.

18 aug. 2026, 23:56 UTC

News

Carvana Co's shares are higher in after-market trading amid concerns over major shareholder Mark Walter's federal investigation and potential stake sale valued at $2 billion.

18 aug. 2026, 23:56 UTC

Correlated Moves

Vicor Corp shares are lower in after-hours trading amid broader market volatility and concerns over rising bond yields and geopolitical tensions.

18 aug. 2026, 23:56 UTC

VF Corp shares are higher in after-market trading following a recovery from an earlier decline. The price remains below its 20-day moving average.

18 aug. 2026, 23:56 UTC

Fastenal Co shares are higher in after-market trading, maintaining performance above the 20-day moving average despite concerns over rising sovereign bond yields.

18 aug. 2026, 23:56 UTC

Paccar Inc shares rose in after-market trading, despite no specific news. The stock remains below its 20-day moving average amid broader market pressures.

18 aug. 2026, 23:56 UTC

Correlated Moves

Morgan Stanley shares are lower in after-market trading amid unusual volatility and rising bond yields, which are pressuring equities and growth prospects.

18 aug. 2026, 23:56 UTC

Social Media

Johnson & Johnson returns the C-CAR039 program to AbelZeta, while discussions about a potential acquisition of Legend Biotech continue. Shares are roughly flat in after-market trading.

18 aug. 2026, 23:56 UTC

Correlated Moves

Campbell Soup Co shares are higher in after-market trading, advancing since Tuesday's close and positioning above the 20-day moving average.

18 aug. 2026, 23:56 UTC

Upbound Group Inc shares are higher in after-market hours, recovering from three consecutive lower closes, though still below the 20-day moving average.

18 aug. 2026, 23:56 UTC

CEVA Inc. shares gained in after-market trading, reaching a high above Tuesday's close, though they remain below their 20-day moving average.

18 aug. 2026, 23:56 UTC

Coca-Cola Co's shares are higher in after-market trading, reflecting a modest increase since Tuesday's close. The stock remains above its 20-day moving average.

18 aug. 2026, 23:52 UTC

News

Social Media

IONQ partners with CMC Microsystems to enhance cloud quantum computing access in Canada. Shares are lower in after-market hours following the announcement.

18 aug. 2026, 23:51 UTC

Agilent Technologies Inc shares declined in after-market hours amid broader market concerns over rising bond yields and inflation linked to geopolitical tensions.

18 aug. 2026, 23:51 UTC

Genpact Ltd shares are lower in after-market hours amid concerns over elevated bond yields and inflation, despite initial gains earlier in the session.

18 aug. 2026, 23:51 UTC

Northrop Grumman shares are higher in after-market hours, remaining above their 20-day moving average and near the upper end of their one-month range.

18 aug. 2026, 23:51 UTC

Correlated Moves

Lennox International Inc shares are higher in after-market trading, reflecting broader trends in correlated assets like Toll Brothers Inc amid rising bond yields.

18 aug. 2026, 23:51 UTC

Correlated Moves

Pultegroup Inc shares are lower in after-market hours, following declines in the Russell 2000 Index and rising concerns over elevated bond yields.

18 aug. 2026, 23:51 UTC

Correlated Moves

Ichor Holdings Ltd shares are lower in after-market hours, influenced by a decline in the Nasdaq 100 Index and rising bond yields.

18 aug. 2026, 23:51 UTC

Monday.Com Ltd. shares declined after-market amid concerns over rising bond yields and inflation. The stock remains above its 20-day moving average.

18 aug. 2026, 23:51 UTC

Cardinal Health Inc. shares are lower in after-market trading, maintaining declines amid broader market concerns over elevated bond yields and inflation linked to geopolitical tensions.

18 aug. 2026, 23:51 UTC

Correlated Moves

Lam Research shares declined in after-market trading, influenced by rising bond yields and broader market trends, including a slight drop in the Nasdaq 100 Index.

Comparație

Modificare preț

Ocugen Inc Așteptări

Obiectiv de preț

By TipRanks

642.75% sus

Prognoză pe 12 luni

Medie 10.25 USD 642.75%

Maxim 12 USD

Minim 8 USD

În baza a 4 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruOcugen Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

4 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 4 analiști care au acordat evaluări ale acțiunilor Ocugen Inc - Dist în ultimele 3 luni.

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is also involved in the development of OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.